Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
about
Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channelsEcologically appropriate xenobiotics induce cytochrome P450s in Apis melliferaDifficulties in Treatment and Management of Epilepsy and Challenges in New Drug DevelopmentAdverse effects of antiepileptic drugs.The importance of drug interactions in epilepsy therapy.Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary careInduction of endogenous pathways by antiepileptics and clinical implications.A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas.Drug-vitamin D interactions: a systematic review of the literatureThe effect of pioglitazone on pharmacokinetics of carbamazepine in healthy rabbits.Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4.Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study.Carbamazepine does not alter biochemical parameters of bone turnover in healthy male adults.Severe hypothyroidism as a complication of anticonvulsant treatment.Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers.Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.Lack of pharmacokinetic interaction between valproic acid and a traditional Chinese medicine, Paeoniae Radix, in healthy volunteers.Influence of acylpeptide hydrolase polymorphisms on valproic acid level in Chinese epilepsy patients.The impact of interacting drugs on dispensed doses of warfarin in the Swedish population: A novel use of population based drug registers.Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
P2860
Q28237504-32DA0A41-CBD5-41AF-9DA2-633D57332419Q28480509-35C2CE09-BF0D-47ED-BCC0-DE29F9767FF9Q33677979-92B27EDF-C9CD-4538-A48D-0AFA167BE123Q33961524-B7E8E783-C9D3-4C47-AFFE-0E33CE2A19E6Q34123652-9D1EBD09-506E-440D-A67D-1DEE59E7022CQ35827051-575B58FE-BD1E-40B8-985C-31025549178CQ36263605-7C89E4E4-BFB2-4690-88B1-ECC5B8F1EB83Q37262792-2ACCFAB2-49A9-4175-85B5-31CBF8DCD380Q38073239-C9352E8A-243F-42F1-83CE-1BEF71324A12Q40316980-0891A937-122F-44E1-A55C-3ABFBC913AE2Q40784945-4C7C7FFF-DADB-474E-AF07-B8C0A6AB0678Q43272818-DF52CAE7-436B-42B9-BE5E-BC6DCD36AD48Q44521539-05A777B7-F011-4E2A-8082-DCA866B94E77Q44792023-F1E0EC09-45A9-4654-B68F-68999BBAF39FQ46521048-517DE69E-C0CF-4EFF-8D3F-CC2E5DF7A656Q46984881-3E9A13F7-EEE4-4D38-AF9C-FE738FF0754DQ47650844-3FBFE253-DE06-41F4-B692-CF97671B310FQ51645804-36645A1B-C00E-4155-915C-6207A77C9081Q51784434-77FF8F41-3491-4EBE-BDB1-0BEA8C355D4AQ52362144-161FFAF6-95E3-46C9-91FA-E185A472A235
P2860
Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
@ast
Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
@en
type
label
Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
@ast
Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
@en
prefLabel
Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
@ast
Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
@en
P2860
P1476
Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
@en
P2093
P2860
P356
10.1046/J.1365-2710.1999.00201.X
P577
1999-04-01T00:00:00Z